NCT00533624 Myfortic vs. Cellcept in Kidney Transplant Recipients Status COMPLETED Phase PHASE2/PHASE3
NCT00532675 Safety Study of LBH589 When Given in Combination With Lenalidomide and Dexamethasone in Adult Patients With Multiple Myeloma. Status COMPLETED Phase PHASE1
NCT00532389 Safety Study of LBH589 When Given in Combination With Bortezomib in Adult Patients With Multiple Myeloma Status COMPLETED Phase PHASE1
NCT00531440 This is a 2-year Follow-up Study to Evaluate the Long-term Effects in Patients Who Completed the Study CRAD001A2307. Status COMPLETED Phase PHASE3
NCT00531063 This is a Two-year Follow-up Study to Evaluate the Long-term Safety, Tolerability and Efficacy of 2 Different Doses of Everolimus Status COMPLETED Phase PHASE3
NCT00529529 Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma Status COMPLETED Phase PHASE3
NCT00529269 Measurement of Patient Reported Outcomes in Korean Renal Transplant Patients With and Without Gastrointestinal (GI) Symptoms Status COMPLETED Phase PHASE4
NCT00526045 Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients Status COMPLETED Phase PHASE1/PHASE2
NCT00523549 The Effects of Systolic Blood Pressure Lowering on Diastolic Function Using Valsartan + Amlodipine in Patients With Hypertension and Diastolic Dysfunction Status COMPLETED Phase PHASE4
NCT00522665 Phase I/Randomized Phase II Study of Second Line Therapy With Irinotecan + Cetuximab +/- RAD001 for Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00522548 Myfortic or CellCept Gastrointestinal Effects in African American Kidney Recipients Status TERMINATED Phase PHASE4
NCT00519324 Efficacy and Safety of Everolimus (RAD001) in Patients With Advanced Gastric Cancer Status COMPLETED Phase PHASE2
NCT00519090 Nilotinib vs Imatinib in Adult Patients With Philadelphia (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) Status TERMINATED Phase PHASE3
NCT00515086 Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM) Status TERMINATED Phase PHASE2
NCT00514514 Study Investigating a Standard Regimen in de Novo Kidney Transplant Patients Versus a Calcineurin Inhibitor (CNI)-Free Regimen and a CNI-low Dose Regimen Status COMPLETED Phase PHASE3
NCT00512993 Postoperative Use of Zoledronic Acid in Breast Cancer Patients After Neoadjuvant Chemotherapy Status COMPLETED Phase PHASE3
NCT00512902 A Study Using The Experimental Drug Called Imatinib (Gleevec) in Subjects With Systemic Sclerosis Status COMPLETED Phase PHASE1/PHASE2
NCT00511043 PTK787 in Refractory or Relapsed Diffuse Large Cell Lymphoma Status TERMINATED Phase PHASE2
NCT00510354 Treatment of Patients With Everolimus and Imatinib Mesylate Who Have Progressive Gastro Intestinal Stromal Tumors (GIST) and Are Resistant to Imatinib Mesylate Status COMPLETED Phase PHASE4